Leishmania-Induced Inactivation of the Macrophage Transcription Factor AP-1 Is Mediated by the Parasite Metalloprotease GP63 by Contreras, Irazú et al.
Leishmania-Induced Inactivation of the Macrophage
Transcription Factor AP-1 Is Mediated by the Parasite
Metalloprotease GP63
Irazu ´ Contreras
1,2,M a r ı ´a Adelaida Go ´mez
1,2, Oliver Nguyen
1, Marina T. Shio
1,2, Robert W. McMaster
3,
Martin Olivier
1,2*
1Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada, 2Centre for the Study of Host Resistance and the Research Institute of
McGill University Health Centre, Montreal, Quebec, Canada, 3Department of Medical Genetics, University of British Columbia, Vancouver Hospital, Vancouver, British
Columbia, Canada
Abstract
Leishmania parasites have evolved sophisticated mechanisms to subvert macrophage immune responses by altering the
host cell signal transduction machinery, including inhibition of JAK/STAT signalling and other transcription factors such as
AP-1, CREB and NF-kB. AP-1 regulates pro-inflammatory cytokines, chemokines and nitric oxide production. Herein we show
that upon Leishmania infection, AP-1 activity within host cells is abolished and correlates with lower expression of 5 of the 7
AP-1 subunits. Of interest, c-Jun, the central component of AP-1, is cleaved by Leishmania. Furthermore, the cleavage of c-
Jun is dependent on the expression and activity of the major Leishmania surface protease GP63. Immunoprecipitation of c-
Jun from nuclear extracts showed that GP63 interacts, and cleaves c-Jun at the perinuclear area shortly after infection.
Phagocytosis inhibition by cytochalasin D did not block c-Jun down-regulation, suggesting that internalization of the
parasite might not be necessary to deliver GP63 molecules inside the host cell. This observation was corroborated by the
maintenance of c-Jun cleavage upon incubation with L. mexicana culture supernatant, suggesting that secreted, soluble
GP63 could use a phagocytosis-independent mechanism to enter the host cell. In support of this, disruption of macrophage
lipid raft microdomains by Methyl b-Cyclodextrin (MbCD) partially inhibits the degradation of full length c-Jun. Together our
results indicate a novel role of the surface protease GP63 in the Leishmania-mediated subversion of host AP-1 activity.
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Introduction
Parasites of the Leishmania genus are the causative agent of
leishmaniasis; a disease distributed worldwide affecting more than
12 million people in 88 countries [1]. Leishmaniasis is a complex
of diseases ranging from self-healing cutaneous lesions to lethal
visceral afflictions [2]. In its mammalian host, Leishmania is an
obligate intracellular pathogen infecting hematopoietic cells of the
monocyte/macrophage lineage. Macrophages are specialized for
the destruction of invading pathogens and priming the immune
response. In order to survive within these cells, Leishmania has
evolved sophisticated mechanisms to subvert macrophage micro-
bicidal functions such as inhibition of nitric oxide (NO) production
and cytokine-inducible macrophage functions [3]. This occurs as
the direct consequence of parasite-mediated activation of protein
tyrosine phosphatases, alteration of signal transduction and
inhibition of nuclear translocation and activity of transcription
factors such as NF-kB, STAT, CREB and AP-1[4,5]. Activated
Protein-1 (AP-1) is an important transcription factor that mediates
gene regulation in response to physiological and pathological
stimuli, including cytokines, growth factors, stress signals, bacterial
and viral infections, apoptosis, as well oncogenic responses [6,7].
AP-1 is formed by homodimers of Jun family members (c-Jun, Jun
B and Jun D), or heterodimers of Jun and Fos family members (c-
Fos, Fos B, Fra 1 and Fra 2). Homodimers within the Fos family
do not occur due to conformational repulsion [8].
Previous studies have reported that the AP-1 transcription factor
is inactivated by Leishmania infection. For instance, activation of
macrophage AP-1 and NF-kB is inhibited by L. donovani
promastigotes through an increase in intracellular ceramide
concentration, which leads to the down-regulation of classical
PKC activity, up-regulation of calcium independent atypical
PKC-f and dephosphorylation of Extracellular Signal-Regulated
Kinases (ERK) [9,10]. Other studies have shown that Leishmania
alters signal transduction upstream of c-Fos and c-Jun by
inhibiting ERK, JNK and p38 MAP Kinases, resulting in a
reduction of AP-1 nuclear translocation [11,12]. However, little is
known about the molecular mechanism (s) by which Leishmania
parasites are able to inactivate this important transcription factor.
Many Leishmania-specific factors such as lipophosphoglycan (LPG),
A2 proteins, cysteine peptidases (CPs) and the protease GP63,
contribute to Leishmania virulence and pathogenicity. LPG has been
implicated in altering phagosome maturation in L. donovani infection
[13].The A2 proteins of L. donovani are involved in intracellular
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implicated in facilitating the survival and growth of the parasite [15].
Furthermore GP63, also known as the major surface protease (MSP),
has been related to resistance to complement-mediated lysis, among
others [16,17]. GP63 is a metalloprotease which belongs to the
metzincin class. It is the most abundant surface glycoprotein of the
parasite and accounts for1% ofthe totalprotein contentof L. mexicana
promastigotes [18]. GP63 of different Leishmania species encode
similar amino acid sequences, although slight substrate specificity
variations have been reported [19]. Specific characteristics of this
class of metalloproteases include a conserved signature motif
HEXXHXXGXXH and an N-terminal pro-peptide that serves to
maintain the pro-enzyme inactive during translation, which is
removed upon protein maturation and activation [20]. The mature
GP63 contains 3 domains: 1) N-terminal (bases ,101-273) which
comprises a structure corresponding to the catalytic module of
metzincin class zinc protease, 2) central domain (bases ,274–391)
and 3) C-terminal domain containing the site of glycosylpho-
sphatidylinositol (GPI) anchor addition (bases ,392–577) [17,18,
20,21]. We have previously shown that this protease actively
participates in the cleavage of NF-kB [5], protein tyrosine
phosphatases (PTP) [22] and actin cytoskeleton regulators [23]. In
this study we have investigated how GP63 contributes to the
inactivation of AP-1 and the degradation of its subunits. Herein, we
report that GP63 enters the host cell via lipid raft microdomains,
independently of parasite internalization, and for the first time show
that it is able to reach the nuclear compartment shortly after infection
where it degrades and cleaves c-Jun and other AP-1 subunits.
Results
Alteration of steady state level of AP-1 upon Leishmania
infection involves down-regulation/degradation of
selected Jun/Fos family members
We have previously studied the effect of Leishmania promastigote
infection on the activity of various macrophage transcription
factors: STAT-1a degradation is proteasome and receptor-
dependent and is mediated through a mechanism involving
PKC-a [4], and cleavage of NF-kB subunits upon Leishmania
infection is in part dependent on GP63 [5]. As AP-1 is an
important transcription factor regulating the expression of many
genes involved in the activation of macrophage functions (TNFa,
iNOS, and IL-12) [24,25,26] critical for the adequate innate
immune response against Leishmania infection, we investigated
the mechanisms underlying AP-1 inactivation upon Leishmania
infection.
To evaluate nuclear translocation and DNA binding activity of
macrophage AP-1 upon infection with Leishmania promastigotes,
Electrophoretic Mobility Shift Assays (EMSA) were performed. As
shown in Figure 1A, AP-1 nuclear translocation was inhibited as
early as 30 min post-infection in L. donovani-infected macrophages.
Furthermore, we observed that other mammalian pathogenic
Leishmania species (L. mexicana and L. major) were able to alter AP-1
DNA binding (Figure 1B). Of interest, we did not observe any
effect on macrophages infected with L. tarentolae, whose pathoge-
nicity is limited to reptilian hosts.
In order to better understand the observed decrease in AP-1
activity, we performed Western Blot (WB) analysis in the total cell
extracts to evaluate the various AP-1 subunits during infection.
Five out of the seven AP-1 subunits (c-Fos, Fra 1, Fra 2, c-Jun and
Jun B) showed decreased expression after infection with L. donovani,
whereas Jun D presented a slight reduction and Fos B was
maintained intact (Figure 2A). To further confirm the presence of
these subunits in the AP-1 complex we used super shift analysis.
This approach uses the incorporation of specific antibodies to
nuclear protein extracts, allowing the visualization of the antibody:
protein: DNA complexes by retarding the migration of the specific
bands in the gel. As shown in Figure 2B, inclusion of antibodies
specific for Fos B, c-Fos, Fra 1, Fra 2, c-Jun, Jun B and Jun D,
demonstrated presence of Fra 1, Fra 2, c-Jun, Jun B and Jun D,
but not c-Fos or Fos B, within the macrophage nuclear AP-1
complex. Importantly, L. donovani infection clearly affected the AP-
1 complex as the bands observed for Fra-1, Fra-2, c-Jun, Jun B
and Jun D in the super shift assay was greatly reduced. Whereas
the c-Fos protein was not detectable by super shift assay, this
protein was still affected by Leishmania infection since less
expression was observed by WB (see Figures 2A and 3), suggesting
that the amount of c-Fos might not be enough to be detected by
super shift assay.
After phosphorylation AP-1 subunits are translocated into the
nucleus where they dimerize with another subunit to form an
active AP-1 complex [6,7,8,27]. To determine the level of
expression of each AP-1 subunit in the different cellular
compartments (cytoplasm vs nucleus), we performed WB analysis
on separated nuclear and cytoplasmic fractions. As shown in
Figure 3, different phenomena can be observed. c-Fos and Fra-1
expression in the cytoplasmic fraction are not altered with
Leishmania infection, but their expression in the nuclear fraction
is decreased in infected macrophages; Fra-2 and c-Jun have
decreased expression in both cytoplasmic and nuclear fractions,
and Fra-2 in the nuclear fraction presents a band with less
migration than the band observed in the cytoplasmic fractions,
possible due to post-nuclear translocation modifications. On the
other hand, Jun-B and Jun-D were detected only in the nuclear
fraction; however, only Jun-B expression is affected by Leishmania
infection. The lower expression of the different subunits in the
nucleus could be due to decreased complex formation and/or
cleavage and further degradation of the subunits, as it is possible to
detect smaller bands (c-Jun and Jun-B).
Author Summary
Leishmaniasis is a tropical disease affecting more than 12
million people around the world. The disease is caused by
the Leishmania parasites that are transmitted to the
mammalian host by a sandfly vector when it takes a
blood meal. The parasites are able to survive and multiply
inside of cells that comprise the primary defence of the
host, the macrophages. We have extensively studied the
mechanism whereby Leishmania escapes from macro-
phage microbicidal functions. Herein we report that the
parasite can inactivate these cells by decreasing the
activity of transcription factors such as Activated Protein-
1(AP-1) that are involved in transcription of genes coding
for antimicrobial functions of macrophages. In this study,
we showed that Leishmania parasites use their most
abundant surface protein GP63 to inactivate the AP-1
transcription factor. Furthermore, we found that GP63
enter into the macrophages independently of parasite
internalization using lipid rich microdomains localized in
the cellular membrane. In addition, GP63 was observed to
reach the nuclear compartment where it cleaves AP-1
subunit proteins. Collectively, our findings reveal a novel
mechanism used by Leishmania to facilitate its survival and
propagation within its mammalian host cells. Better
knowledge concerning the mechanisms whereby this
pathogen can escape the innate immune response may
help to develop new anti-Leishmania therapy.
AP-1 Inactivation by Leishmania Protease GP63
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AP-1 inactivation
Leishmania surface molecules such as LPG and GP63, among
others, play important roles as virulence factors and modulators of
host cell signalling. LPG, for instance, has been implicated in the
interference of phagolysosome maturation and inactivation of
PKC signalling [13,28]. GP63 has been related to resistance to
complement-mediated lysis, migration of Leishmania parasites
through the extracellular matrix by degradation of casein,
fibrinogen and collagen [16,21] and inhibition of JAK/STAT
signalling by modulation of PTP activities [22]. To address the
role of LPG and GP63 in AP-1 inactivation we performed EMSA
with extracts from cells infected with Leishmania mutants for these
two surface molecules. As shown in Figure 4A, LPG is not involved
in the AP-1 degradation induced by Leishmania infection since
DNA binding in macrophages infected with either L. donovani or L.
donovani LPG
2/2 promastigotes was similarly altered. Importantly,
however, we observed that cells infected with an L. major strain
lacking GP63 (L. major GP63
2/2) [29] showed normal AP-1 DNA
binding capacity, compared to uninfected controls. This suggests
that GP63 but not LPG is highly involved in the mechanism
responsible for the inactivation of AP-1 transcription factor.
To further elucidate the role of GP63, we performed WB
analysis of all the AP-1 subunits of macrophages infected with L.
major, L. major GP63
2/2 and L. major GP63 Rescued. Results
obtained further revealed that in the absence of GP63, no
degradation or cleavage of any AP-1 subunit was evident
(Figure 4B); supporting the finding that AP-1 activity is unaffected
in L. major GP63
2/2-infected macrophages.
In addition, to validate the role of GP63 on AP-1 activity we
verified the expression of IL-12 transcripts, as it is known that AP-
1 regulates its transcription [24]. As shown in the Figure S1, LPS-
induced IL-12 expression is fully blocked by all infectious
Leishmania species but not by L. major GP63
2/2 and L. tarentolae.
As expected, the JNK/c-Jun inhibitor has completely inhibited
LPS-induced IL-12 transcripts.
GP63 action requires macrophage lipid raft and is not
dependent on parasite phagocytosis
Leishmania GP63 can be found in three different forms: 1)
Intracellular GP63, 2) Surface GPI-anchored GP63 and 3)
secreted or released GP63 [21,30]. For GP63 to target its
intracellular macrophage substrates, it needs to gain access to or
be internalized by the macrophage. To explore whether the
Figure 1. Infection with different species of Leishmania inhibits AP-1 DNA binding activity. (A) B10R macrophages were infected for 0.5, 1,
3 and 6 hr with L. donovani, at a ratio 20:1 parasite/macrophage. Nuclear proteins were isolated and EMSA for AP-1 DNA binding activity was
performed. A consensus DNA sequence for SP-1 binding was used as non-specific competitor (NSCO). A 1006molar excess of AP-1 probe was used
as a specific competitor (SCO). (B) B10R macrophages were infected for 1 hr with L. mexicana, L. major, L donovani infantum or L. tarentolae and
treated as in (A).
doi:10.1371/journal.ppat.1001148.g001
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the cell, murine macrophages were pre-treated with the phago-
cytosis inhibitor cytochalasin D which inhibits actin polymeriza-
tion, therefore blocking internalization by phagocytosis (Figure
S2A). We used c-Jun as a model protein to evaluate the cleavage
and degradation of the AP-1 subunits. WB analysis showed that
Figure 2. AP-1 subunits are degraded after infection with Leishmania parasites. (A) Western blot analysis of AP-1 subunit proteins extracted
from B10R macrophages infected with L. donovani for 1 and 3 hr. b-actin was used as a loading control. (B) Super shift assays of B10R macrophages
infected with L. donovani for 1 hr. Nuclear proteins were super shifted using antibodies against c-Jun, Jun B, Jun D, c-Fos, Fos B, Fra 1 and Fra 2 AP-1
subunits.
doi:10.1371/journal.ppat.1001148.g002
Figure 3. Subcellular localization of AP-1 subunits. B10R macrophages were infected with L. donovani for 1 and 3 hr. Cytoplasmic and nuclear
distribution of the AP-1 subunits was monitored by Western Blot analysis. b-actin was used as a loading control for cytoplasmic fraction, and Jun D for
nuclear fraction.
doi:10.1371/journal.ppat.1001148.g003
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expression (Figure 5A). To confirm this, we incubated macro-
phages with the culture supernatant of L. mexicana promastigotes,
which is rich in soluble GP63 [18,31]. WB showed that even in the
absence of the parasite, c-Jun degradation was observed
(Figure 5B).
Since phagocytosis seems not to be completely required in the
internalization of GP63 we addressed whether GP63 internaliza-
tion could be dependent on lipid raft-mediated endocytosis, given
the fact that GP63 is an excreted and membrane-GPI anchored
protein. On the other hand, lipid raft microdomains are highly
dynamic membrane domains rich in cholesterol and sphingolipids,
and present high affinity for proteins containing GPI anchors
[32,33,34]. In order to examine the possible role of host lipid raft
microdomains in GP63 internalization, we pre-treated cells with a
non-cytotoxic dose (Figure S2B) of the cholesterol chelator and
inhibitor of lipid raft integrity methyl-b-clyclodextrin (MbCD)
prior to infection. As shown in Figure 5C, full length c-Jun was not
degraded in cells infected under these conditions, although
interestingly, a cleavage fragment was still observed. Pre-treatment
of macrophages with MbCD and subsequent incubation with L.
mexicana supernatant showed that lipid raft disruption altered
internalization of parasite-free soluble GP63 and also impaired c-
Jun degradation (Figure 5D). As shown in Figure S3, confocal
microscopy confirmed an interaction between lipid raft micro-
domains and GP63, since in macrophages infected with L. major,
GP63 (green) partially co-localized with the lipid raft marker
Choleratoxin B (red). Furthermore, we have previously shown
that, pre-treatment with MbCD before infection abrogates GP63
internalization [22]. To determine if MbCD had any effect over
the c-Jun expression we performed a time course analysis of
macrophages stimulated with MbCD. As shown in Figure S4A,
there was no alteration in the expression of c-Jun after 2 hr of
incubation of the macrophages with the drug. Together these data
strengthen the hypothesis that GP63 uses lipid raft microdomains
for internalization independent of parasite entry.
To evaluate the role of the GPI anchor in mediating GP63
internalization via lipid raft microdomains, macrophages were
incubated with a GPI-deficient recombinant GP63 (rGP63) and c-
Jun degradation was monitored. WB analysis evidenced that
neither degradation nor cleavage of c-Jun occurred (Figure 5E) in
the presence or absence of MbCD, similarly to what we have
Figure 4. Role of Leishmania surface molecules in the inactivation of AP-1. (A) EMSA for AP-1 DNA binding activity of nuclear extracts from
B10R macrophages infected for 1 hr with L. donovani 1S2D (LPG
+/+), L. donovani LPG
2/2, L. major (WT), L. major GP63
2/2 or L. major GP63 Rescued
(GP63 R) promastigotes. A consensus DNA sequence for SP-1 binding was used as non-specific control (NSCO). A 1006molar excess of AP-1 probe
was used as a specific competitor (SCO). 1 hr stimulation with LPS (100 ng/ml) was used as a positive control for the induction of AP-1 DNA binding.
(B) Macrophages were infected for 1 hr with L. major (WT), L. major GP63
2/2 or L. major Rescued promastigotes at 20:1 ratio. WB of AP-1 subunits
was performed with the total cell lysate. b-actin was used as a loading control.
doi:10.1371/journal.ppat.1001148.g004
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although rGP63 is still internalized in macrophages to a limited
extent, perinuclear localization was never detected [22].
To demonstrate that the less expression and cleavage of c-Jun
observed in this set of experiments were occurring inside the cells
and not as an effect of proteolysis during the preparation of the
lysates, we included two experiments as controls; first, we lysed the
cells using sample loading buffer 16and the samples were boiled
right after, to stop the proteolysis; second, we added 1 mM of
phenanthroline (a Zn chelator [35]) to the lysis buffer to abrogate
post-infection GP63 activity. In both experiments, we observed
that cleavage of c-Jun under these conditions still occurs,
suggesting that the cleavage of c-Jun occurs inside the cell and
not during the sample preparation (Figure S4B and S4C). In
addition, to establish whether GP63 proteolytic activity is critical
for c-Jun cleavage in the macrophage, L. mexicana culture
supernatant was treated with the GP63 inhibitor phenanthroline
prior to its incubation with macrophages. As shown in the
Figure S4D, phenanthroline fully inhibited GP63-mediated c-Jun
degradation.
GP63-mediated c-Jun cleavage occurs at perinuclear
compartment
One of the most surprising elements of the evidence presented
above was the fact that GP63 is able to act on its substrate proteins
within the nucleus of its host cell. In order to further demonstrate
that GP63 reaches the nucleus, we separated cytoplasmic and
nuclear proteins from macrophages infected with L. major, L. major
GP63
2/2 and L. major GP63 Rescued. WB analysis using an anti-
GP63 antibody revealed that this protease is present in both
fractions of Leishmania-infected cell extracts. As expected, there was
no GP63 in macrophages infected with L. major GP63
2/2 or the
uninfected control (Figure 6A). Confocal microscopy of Leishmania-
infected macrophages confirmed that GP63 reaches the nuclear
membrane as early as 1 hr post-infection (Figure 6B). In order to
demonstrate the purity of our fractions, we performed WB of the
cytoplasmic and nuclear proteins against the lysosomal marker
LAMP-1, the ER specific marker (the KDEL protein - Lys-Asp-
Glu-Leu endoplasmic reticulum protein retention receptor),
histone 2B (nuclear marker), and actin (cytoplasm marker). Figure
S5 shows that actin, LAMP-1 and KDEL are only present in the
Figure 5. GP63 delivery into the host cell is mediated via lipid raft. (A) B10R macrophages were pre-treated or not with 2 mM cytochalasin D
for 1 hr and then infected with L. mexicana for indicated times. (B) B10R macrophages were incubated with either with whole parasite or culture
supernatant of L. mexicana promastigotes. Macrophages were pre-treated or not with 20 mM of methyl b-ciclodextrin (MbCD) for 1 hr and infected
with L. mexicana promastigotes (C), incubated with L. mexicana supernatant (D) or recombinant GP63 (rGP63) (E). For all the Figures, total cell
extracts and b-actin as a loading control were used.
doi:10.1371/journal.ppat.1001148.g005
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nuclear fraction, and this way we are confident to say that GP63
was present in both protein fractions.
In order to confirm nuclear interaction of GP63 with c-Jun we
performed a Co-Immunoprecipitation (IP) assay. c-Jun was
immunoprecipitated from nuclear extracts of Leishmania-infected
macrophages and subjected to WB analysis of GP63. This result
revealed a band around 65 kDa, confirming the interaction
between nuclear c-Jun and GP63 in the macrophages infected
with L. major and L. major GP63 Rescue, but not with L. major
GP63
2/2 as is shown in Figure 7.
To further support that degradation of c-Jun could occurs in the
nucleus we performed confocal microscopy. As shown in Figure 8A
(upper panel), c-Jun (red) is localized inside the nucleus in
uninfected cells. However, after 1 hr of infection GP63 was
detected in the perinuclear area and the fluorescence intensity of c-
Jun was considerably diminished (Figure 8A, lower panel), such
reduction in the fluorescence was not observed in macrophages
infected either with L. major GP63
2/2 or L. tarentolae (Figure 8C
upper and lower panels, respectively). The upper panel of
Figure 8B shows partial co-localization between the nuclear stain
(blue) and GP63 (green) in the periphery of the nucleus, giving a
Figure 6. Subcellular localization of GP63. (A) B10R macrophages were infected for 1 hr with L. major (WT), L. major GP63
2/2 or L. major GP63
Rescued and GP63 distribution in the cytoplasmic and nuclear extracts was monitored by WB. b-actin and Jun B were used as fractioning controls. (B)
B10R macrophages were infected for 1 hr with L. major (WT). GP63 is shown in green and nuclei were stained with DAPI (blue).
doi:10.1371/journal.ppat.1001148.g006
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Jun (red) versus nucleus (blue) co-localization, clearly reveals that
c-Jun is absent from perinuclear area as this one is solely stained in
blue (Figure 8B, lower panel). To discard possible unspecific
signals in the confocal micrographs we included specific isotype
and secondary antibody controls (Figure S6B). Collectively, our
results suggest that GP63 reaches the perinuclear area of the
cell shortly after macrophage-parasite contact occurred leading to
degradation and cleavage of various members of AP-1 subunits,
leading to its inability to dimerize and bind DNA and
therefore, altering AP-1 transcriptional activity on genes under its
regulation.
GP63 can directly cleave c-Jun
To further understand the direct effect of GP63 on c-Jun, we
used a purified GST tagged-c-Jun protein and incubated it with
Leishmania promastigotes of different species (including L. donovani,
L. mexicana, L. major, L. major GP63
2/2 and L. major GP63
Rescued). WB analysis showed that direct contact of parasites
expressing GP63 and c-Jun protein is sufficient to induce c-Jun
degradation (Figure 9A). This was corroborated by the reduction
of c-Jun degradation when incubated with the GP63
2/2 strain.
Figure S7 shows that L. tarentolae has no effect on the degradation
of GST-c-Jun.
GP63 recognizes a four amino acid motif in its target protein
substrates based on amino acid characteristics: polar/hydropho-
bic/basic/basic amino acids (P1-P 91-P92-P93) [19]. Sequence
analysis of AP-1 subunits revealed putative cleavage sites within c-
Jun, Jun B, Jun D and c-Fos (Figure 9B). Of interest, one of the
sequence-identified cleavage sites of c-Jun was found between the
leucine zipper and the DNA binding domain as shown in
Figure 9C. In addition, this motif is found at amino acids 271-
275, which will generate cleaved fragments with molecular weight
similar to the one detected by WB of lysates from infected cells
(,30 kDa).
Collectively, these data indicate that the Leishmania protease
GP63 actively participates in altering the DNA binding capacity of
AP-1 as a consequence of the diminished expression and cleavage
of its subunits. These data further corroborate a mechanism
whereby GP63 can enter the cell using lipid raft microdomains,
and show for the first time that GP63 reaches the perinuclear area
where it proteolytically degrades AP-1 subunits.
Discussion
Leishmania parasites have evolved many mechanisms to under-
mine macrophage signalling pathways in order to survive and
replicate inside these cells. For instance, parasite-mediated
activation of macrophage PTPs leads to protein dephosphoryla-
tion resulting in the inactivation of transcription factors controlling
the expression of many genes required for the effective activation
of the innate immune response [36], and macrophage effector
functions such as NO production [37]. We have previously
reported that Leishmania promastigote infection induces degrada-
tion and inactivation of some transcription factors. For example,
STAT 1 is inactivated by a proteasome mediated mechanism [4],
and NF-kB activity is altered in a cleavage-dependent fashion [5].
We show that cleavage of p65 generates an active fragment, p35,
which is able to translocate into the nucleus, where it dimerizes
with p50 to induce specific chemokine gene expression. Interest-
ingly this cleavage event was found to occur in the macrophage
cytoplasm in a GP63-dependent mechanism [5].
Along with STAT and NF-kB, AP-1 is responsible for the
transcription of iNOS [38]. NO is a by-product of iNOS-mediated
conversion of L-arginine to L-citruline and is essential for the
control of Leishmania infection [3,36]. Among other genes
regulated by AP-1 in macrophages and known to be affected by
Leishmania infection are TNFa, IL-1b and IL-12 [24,25,26,39].
The breadth and importance of the immunological functions of
AP-1 highlights how detrimental its degradation is to host defence
against Leishmania infection. Previously, Descoteaux and Matla-
shewski (1989) demonstrated that the c-fos gene, one of the main
activators of AP-1, was down-regulated due to abnormal PKC
signalling [40]. More recently Ghosh and colleagues (2002)
reported Leishmania-dependent inactivation of both AP-1 and
NF-kB in a ceramide dependent mechanism, where increased
levels of intracellular ceramide conducted to the down-regulation
of classical PKC activity and impartment of the phosphorylation of
ERK, which results in decreased AP-1 activation [10]. These
previous reports have given some indication of AP-1 inactivation
by Leishmania. Here we further demonstrated the molecular
mechanisms involved in the AP-1 inactivation by Leishmania
parasites and its impact on IL-12 expression.
We have found that infection with several Leishmania species
alters the DNA binding capacity of AP-1. In particular, we have
shown that the parasite metalloprotease GP63 is responsible for
Figure 7. c-Jun interacts with GP63 in nuclear fraction. Proteins from nuclear extracts of macrophages infected for 1 hr with L. major (WT), L.
major GP63
2/2 and L. major GP63 Rescued (GP63 R) and nuclear proteins were immunoprecipitated using an anti-c-Jun antibody. GP63 and c-Jun
co-immunoprecipitation was evaluated by western blot. H denotes the heavy chain of the immunoglobulin.
doi:10.1371/journal.ppat.1001148.g007
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PLoS Pathogens | www.plospathogens.org 8 October 2010 | Volume 6 | Issue 10 | e1001148Figure 8. GP63 is localized in the perinuclear compartment. (A) Confocal microscopy images of B10R macrophages showing co-localization of
nuclei (blue), c-Jun (red) and GP63 (green) in non-infected (upper panel) and cells infected for 1 hr with L. major (lower panel). (B) Confocal
microscopy analysis to evaluate nuclear localization of GP63 (green) and nuclear distribution (upper panel) and degradation of c-Jun (red) in
macrophages infected 1 hr with L. major (lower panel). Blue shows cell nuclei. (C) co-localization of nuclei (blue), c-Jun (red) and GP63 (green) in B10R
macrophages infected for 1 hr with L. major GP63
2/2 or L. tarentolae.
doi:10.1371/journal.ppat.1001148.g008
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PLoS Pathogens | www.plospathogens.org 9 October 2010 | Volume 6 | Issue 10 | e1001148Figure9.Parasite-freeGP63issufficienttodegradec-Jun.(A)ExogenousGST-c-Junwas incubatedwith500 mlo fL.donovani,L. mexicana,L. major,
L. major GP63
2/2 or L. major GP63 Rescued for 30minutes, and degradation of c-Junwas visualized by WB using anti-GST antibody.(B) Jun B, Jun D, c-Fos,
Fos B, Fra 1 and Fra 2 protein sequences showing putative GP63 cleavage sites. (C) c-Jun sequence analysis showing the putative site of GP63 cleavage.
doi:10.1371/journal.ppat.1001148.g009
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PLoS Pathogens | www.plospathogens.org 10 October 2010 | Volume 6 | Issue 10 | e1001148this DNA binding alteration and is able to induce the
degradation/down-regulation and cleavage of c-Jun, the central
component of the AP-1 transcription factor [41], as well of other
components including c-Fos, Fra-1, Fra-2 and Jun B. We provide
evidence that GP63 exerts its effect by its internalization into the
host cell, in a mechanism that is independent of parasite
internalization, and induces AP-1 proteolysis within the nucleus
or in the nuclear membrane.
The present study corroborates along with previous studies
(Ghosh et. al) that AP-1 is down-regulated by Leishmania parasites.
Alteration of AP-1 activity varies according to the pathogen, for
instance it has been shown, that the hepatitis C virus alters MAP
kinases and AP-1 to accelerate the cell cycle progression, helping
the development of hepatocellular carcinoma and HCV develop-
ment [42]. Another example is the Edema toxin produced by
Bacillus anthracis; this toxin is able to up-regulate macrophage gene
expression, among them genes that are known to be involved in
inflammatory responses, regulation of apoptosis, adhesion, im-
mune cell activation, and transcription regulation. Interestingly
this up-regulation was found to correlate with induced activation
of AP-1 and CAAAT/enhancer-binding protein-beta [43]. In
contrast with these reports where different pathogens up-regulate
AP-1 to survive inside the host cell, herein we have shown how this
transcription factor is down-regulated after Leishmania infection in
a cleavage-dependent manner. Whether AP-1 down-regulation is
a general mechanism used by different intracellular protozoa
requires further investigation.
The AP-1 transcription factor is formed by dimers of Jun and
Fos family members. In addition, the Jun proteins can dimerize
with other proteins that share the leucine zipper region such as
ATF-1 and ATF-2 [8,27]. Although we did not test other non-
classical AP-1 subunits, we demonstrated that at least 5 of the
classical subunits belonging the Jun and Fos families are degraded
by the parasite within 1 hr of infection. Of interest, c-Jun subunit,
one of the main activators of AP-1 along with c-Fos, is cleaved
generating a GP63-mediated 30 kDa fragment. The cleaved
product would be unable to dimerize and bind DNA, as it has
been demonstrated that truncated c-Jun deprived of either the
leucine zipper or the DNA binding domain results in only
marginal AP-1 transactivation [41,44,45]. The generation of c-Jun
fragment by GP63 can explain the lower AP-1 binding activity
observed in the EMSA experiment. Furthermore, Fos B, which is
not cleaved or degraded and also apparently absent in AP-1
complexes (Figure 2B), lacks putative GP63 cleavage sites.
Surprisingly Jun D presents two putative sites of cleavage by
GP63. However, we did not detect either complete degradation/
down-regulation or cleavage products. One possible explanation is
that the structural conformation of this protein renders these sites
unavailable for GP63-Jun D interaction.
GP63 is known to interact with various substrates. For instance
we have recently reported that Leishmania GP63 impacts the
stability of cortactin and caspase-3, and negatively regulates p38
kinase activity [23]. Furthermore, we have shown that GP63
cleaves host PTPs resulting in enzymatic activation and leading to
JAK 2 dephosphorylation, and inhibition of NO production in
IFN-c primed and infected macrophages [22]. Our current study
further supports the important role of GP63 as a negative
regulator of host cell functions, actively participating in the
pleiotropic effects excreted by Leishmania parasite to suppress the
immune response, our results showed that internalization of GP63
by cells from innate immune response is independent of parasite
internalization, as our data revealed GP63 proteolytic activity was
not affected by inhibition of phagocytosis, but clearly abolished by
a lipid raft disruptor, strongly suggesting that lipid rafts
microdomains are important for internalization of GP63. Proteins
that have a GPI anchor have affinity for lipid rafts, and it has been
reported that these rafts recognize these GPI anchors allowing the
entrance of GPI-bearing proteins in endocytic vesicles [33,34]. In
addition, Brittingham and collaborators showed interaction of
GP63 with the fibronectin receptor (a4b1), that also translocate
into the lipid rafts microdomains [46], suggesting that GP63 could
have two different ways to get access into the cell: 1) GPI-anchor
(native and excreted) and 2) receptor mediated (RGP63).
Additionally, we have shown that the GPI anchor is important
for the internalization of GP63 since recombinant GP63 (rGP63)
lacking the GPI anchor is less internalized [22]. Most importantly,
GPI anchor seems to be required for the cellular localization of
GP63 since rGP63 is localized inside intracellular compartments
whereas GPI-GP63 (native protein) is found within nuclear
membrane (see Figure 6). Despite this evidence we have not
excluded the possibility that GP63 could use other mechanisms to
enter the cells, such as micropinocytosis or classical endocytosis
pathways.
One of the main finding of this research is the macrophage
nuclear localization of GP63. One plausible mechanism is by the
recognition of its GPI domain by the recently described lipid
microdomains rich in cholesterol and sphingolipids in the nuclear
membrane [47]. Another possible mechanism for the internaliza-
tion of GP63 inside the nucleus is the presence of a nuclear
localization signal (NLS)-like motif (Figure S8) in the GP63
sequence. Nuclear proteins are usually transported inside the
nucleus by recognition of a NLS, which usually consist of short
chains of basic amino acids with the signature motif K-K/R-X-K/
R [48]. These NSLs are recognized by the adaptor molecule
importin a, which forms a hetorodimer with the transporter
receptor importin b. The importin a/b-NSL-cargo complex is
then translocated through the nuclear pore complex [48,49]. The
exact mechanisms of how the nuclear translocation of GP63
occurs are currently under investigation.
In summary, GP63 seems to preferentially target AP-1 subunits
within the nuclear membrane, altering its DNA binding capacity.
Given the critical role of this transcription factor in the
transcription of several genes involved in the innate immune
response, alterations in AP-1 activity can dramatically contribute
to the down-regulation of innate immune functions observed
during the early stages of Leishmania infection. Therefore, this novel
mechanism of evasion by Leishmania further demonstrates the
complex negative regulatory mechanisms developed by the
parasite, which has permitted its adaptation to the harsh
intracellular environment leading to its survival and propagation
within its mammalian host.
Materials and Methods
Cell culture, macrophage infection and reagents
Immortalised murine bone marrow derived macrophages B10R
cell line were maintained at 37uCi n5 %C O 2 in Dulbecco’s
Modified Eagle medium (DMEM) supplemented with 10% heat
inactivated FBS (Invitrogen, Burlington, ON, Canada) and
100 U/ml penicillin 100 mg/ml streptomycin and 2 mM of L-
glutamine (Wisent, St-Bruno, QC, Canada). Leishmania promasti-
gotes (L. donovani infantum, L. donovani 1S2D, L. donovani R2D
(LPG
2/2), L. mexicana, L. major A2 (WT), L. major GP63
2/2, L.
major GP63 Rescued [29] and L. tarentolae) were grown and
maintained at 25uC in SDM-79 culture medium supplemented
with 10% FBS by bi-weekly passage. Macrophages were infected
at parasite to macrophage ratio 20:1 with stationary phase
promastigotes for the times specified in each Figure legend. Using
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infected cells in 1 or 2 hr, respectively. When chemical inhibitors
were used, 2 mM cytochalasin D (Sigma-Aldrich, St-Louis MO,
USA) and 20 mM Methylb-cyclodextrin (MbCD) (Sigma-Aldrich,
St-Louis MO, USA), cells were treated 1 hr prior to infection and
the inhibitor remained throughout the infection time.
Electrophoresis Mobility Shift Assay (EMSA) and
supershift assays
B10R macrophages (2610
6) were infected, washed three times
with Phosphate Buffered Saline (PBS) to remove non-internalized
parasites, and processed for nuclear extraction as previously
described [4,50]. Briefly, macrophages were collected in 1 ml of
cold PBS, centrifuged and pellets were resuspended in 400 mlo fi c e -
cold buffer A (10 mM HEPES, 10 mM KCl, 0.1 mM EDTA,
0.1 mM EGTA, 1 mM DTTand 0.5 mM of PMSF) and incubated
15 min on ice. Twenty five ml of IGEPAL 10% (Sigma-Aldrich, St-
Louis MO, USA) were added, and samples vortexed for 30 sec.
Nuclear proteinswerepelleted bycentrifugation and resuspended in
50 ml of cold buffer C (20 mM HEPES, 400 mM NaCl 1 mM
EDTA, 1 mM EGTA 1 mM DTT and 0.5 mM PMSF).
Protein concentrations were determined by Bradford assay (Bio-
Rad, Hercules CA, USA). 6 mg of nuclear proteins were incubated
for 20 min at room temperature with 1 ml of binding buffer
(100 nM Hepes pH 7.9, 8% v/v glycerol, 1% w/v Ficoll, 25 mM
KCl, 1 mM DTT, 0.5 mM EDTA, 25 mM NaCl, and 1 mg/ml
BSA) and 200 ng/ml of poly (dI-dC), 0.02% bromophenol blue
and 1 mlo fc-P
32labeled oligonucleotide containing a consensus
sequence for AP-1 binding complexes (59-CGTTTGATGACT-
CAGCCGGAA-39) (Santa Cruz Biotechnology Inc, Sta Cruz CA,
USA). After incubation, DNA-protein complexes were resolved by
electrophoresis in non-denaturing polyacrylamide gel 5% (w/v).
Subsequently gels were dried and autoradiographed. Competition
assays were conducted by adding a 100-fold molar excess of
homologous unlabeled AP-1 oligonucleotide, or the non-specific
competitor sequence for SP-1 binding (59-ATTCGAATCG-
GGGCGGGGCGAGC-39).
For supershift assay, 2 mg of nuclear protein extract were
incubated for 1 hr at room temperature with binding buffer, poly
(dI-dC), 0.02% bromophenol blue, labeled oligonucleotide and
4 mg of individual specific antibodies (a-c-Jun, Jun B, Jun D, c-Fos,
Fos B, Fra 1 or Fra 2; Santa Cruz Biotech Inc, Sta Cruz CA,
USA). Complexes were resolved on standard non-denaturing
polyacrilamide gel 5% (w/v).
Western blot
Infected and non infected cells (1610
6) were washed 3 times with
PBS and lysed with cold buffer (50 mM Tris (pH 7), 0.1 mM,
0.1 mM EGTA, 0.1% 2-mercaptoethanol, 1% NP-40, 40 mg/ml
aproptinin and 20 mg/ml of leupeptin). Proteins were dosed by
Bradford (Bio-Rad, Hercules CA, USA), and 30 mg of proteins were
separated by SDS-PAGE, and transferred onto PVDF membranes
(GE healthcare, Piskataway NJ, USA). Membranes were blocked in
5% non-fat dry milk, washed and incubated for 1 hr with a-c-Jun
(BD Biosciences, San Jose, CA, USA), a-Jun B, a-Jun D, a-c-Fos, a-
Fos B, a-Fra 1 and a-Fra 2 (Santa Cruz Biotech Inc. Sta Cruz CA,
USA). After washing, membranes were incubated 1 hr with a-
mouse or a-rabbit HRP-conjugated antibody (GE healthcare,
Piskataway NJ, USA), and developed by autoradiography.
Imunoprecipitation
B10R macrophages (10610
6) were infected with either L. major
A2, or L. major GP63
2/2 or L. major GP63 Rescued for 1 hr, and
nuclear proteins were extracted as previously described in [5]. c-
Jun was immunoprecipitated from pre-cleared nuclear extracts
with 2 mg antibody, followed by addition of 12.5 ml (packed
volume) of protein A/G PLUS agarose beads (Santa Cruz Biotech
Inc. Sta Cruz CA USA). Beads were washed three times and
bound proteins were analyzed by WB as described above.
Confocal microscopy
B10R macrophages (0.5610
6) were plated ON in glass cover
slips. After infection for 30, 60 and 180 min cells were gently
washed 3 times with PBS, and then fixed with 4% p-formaldehyde
for 30 min at 4uC. Slides were permeabilized for 5 minutes with
PBS containing 1% BSA and 0.05% NP-40 and blocked with 5%
non-fat dry milk for 1 hr. Incubation with primary antibody a-c
Jun or a-c-Fos or a-GP63 mouse monoclonal antibody clone #96
[51] was conducted in humid dark chamber for 1 hr at room
temperature. After three washes with PBS, cells were incubated
with secondary antibody (Alexa Fluor 488 or 594, from Molecular
probes, Burlington ON, Canada) for 1 hr. Nuclei were stained
with propidium iodide or DAPI for 10 min and slides were
mounted in permaflour medium (Thermo Co. Waltham MA,
USA). Images were taken using an Olympus FV1000 confocal
microscope and a Zeiss LCS 500.
IL-12 mRNA expression analysis
B10R macrophages (10610
6) were infected with either L. major
A2, L. major GP63
2/2, L. major GP63 Rescued or L. tarentolae for
18 hr or treated with 20 mM of JNK inhibitor SP600125 for 1 hr.
Thereafter cells were stimulated with 100 ng/ml of LPS for 6 hr
and RNA extracted using TRIzol reagent according to the
manufacturer’s instruction (Invitrogen Canada). Reverse tran-
scriptase was performed using oligo(dT) primers. Quantitative
relative PCR was performed using Invitrogen Platinum qPCR
Super-Mixes and 0.4 mM primer in 25 ml and the following
parameters: 50uC for 2 min and 95uC for 3 min (95uC for 20 s,
60uC for 30 s, 72uC for 20 s, 80uC (reading step) for 20 s) for 40
cycles followed by a melting curve. Annealing temperature was
60uC. IL-12 primer sequences: 59-GGA AGCACG GCA GCA
GAA TA-39 and 39-AAC TTG AGG GAG AAG TAGGAA
TGG-59.
Supporting Information
Figure S1 LPS-induced IL-12 expression is regulated by
Leishmania in a GP63 dependent manner. B10R macrophages
were infected (1:20 ratio) with L. major, L. major GP63
2/2, L. major
GP63 Rescued or L. tarentolae stationary promastigotes for 18 hr or
treated with 20 mM of JNK/c-Jun inhibitor - SP600125. After
infection, mRNA was extracted and submitted to qRT-PCR. Data
shows mean 6 SEM of three different experiments.
Found at: doi:10.1371/journal.ppat.1001148.s001 (0.25 MB
TIF)
Figure S2 Efficacy of cytochalasin D and cytotoxicity of MbCD.
(A) % of infected cells pre-treated with 2 mM/ml of cytochalasin D
1 hr before infection with L. mexicana (1 hr infection) (B)
Cytotoxicity of MbCD in B10R macrophages treated for 1 hr
with indicated doses of MbCD using the XTT metabolizing assay.
Found at: doi:10.1371/journal.ppat.1001148.s002 (0.24 MB TIF)
Figure S3 GP63 partially co-localizes with lipid raft domains.
(A) B10R macrophages were incubated with L. major supernatant
for 1 hr and then stained for confocal microscopy to evaluate co-
localization of lipid rafts domains and GP63. The lipid raft marker
cholera toxin B (CTxB) is shown in red and GP63 is labelled in
AP-1 Inactivation by Leishmania Protease GP63
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major for 1 hr and then stained with unspecific anti-mouse IgG2a
followed by anti-mouse Alexa 488 or infected and then incubated
with anti-mouse Alexa 488.
Found at: doi:10.1371/journal.ppat.1001148.s003 (0.68 MB TIF)
Figure S4 Controls for c-Jun cleavage and GP63 activity. (A)
B10R macrophages were incubated for 5, 30, 60 and 120 minutes
with MbCD (20 mM) and total cell lysates were subjected to WB
against c-Jun. (B) B10R macrophages were infected with stationary
phase promastigotes for 5, 30 and 60 minutes, after infection cells
were washed, lysed with 100 ml of SLB 16 and boiled for 5
minutes. Samples were subjected to WB against c-Jun. (C) B10R
macrophages were infected as in (B) and cells were lysed with lysis
buffer containing 1 mM of phenantroline. Total cell extracts were
subjected to WB against c-Jun. (D) L. mexicana supernatant was
pre-treated with 1 mM of phenanthroline (phen) for 1 hr. After,
supernatant from L. mexicana (mex), L. mexicana + phen, L. tarentolae
(Tar), L. major (Mj), L. major GP63
2/2 (KO) were added to B10R
macrophages and incubated for 1 hr. Total cell extracts were
subjected to WB against c-Jun, GP63 and actin. For all the figures
actin was used as loading control.
Found at: doi:10.1371/journal.ppat.1001148.s004 (0.66 MB TIF)
Figure S5 Purity of cytoplasmic and nuclear fractions. B10R
macrophages were infected with L. major, L. major GP63
2/2 or L.
major GP63 Rescued stationary promastigotes for 1 hr. After
infection, cytoplasmic and nuclear proteins were separated and
subjected to WB against lysosomal marker LAMP-1, ER specific
protein KDEL receptor, actin, histone and GP63 antibodies.
Found at: doi:10.1371/journal.ppat.1001148.s005 (0.39 MB TIF)
Figure S6 Negative control to confocal experiments. B10R
macrophages were infected with L. major and cells were stained
with unspecific anti-mouse (IgG2a) or anti-rabbit antibodies
followed by secondary antibody (Alexa 488 or Alexa 546
respectively) or only stained with anti-mouse (Alexa 488) or anti-
rabbit (Alexa 546) antibodies.
Found at: doi:10.1371/journal.ppat.1001148.s006 (1.27 MB TIF)
Figure S7 L. tarentolae has no effect over recombinat c-Jun.
Exogenous GST-c-Jun was incubated with 500 mlo fL. donovani, L.
mexicana,o rL. tarentolae for 30 min and degradation of c-Jun was
visualized by WB using anti-GST antibody.
Found at: doi:10.1371/journal.ppat.1001148.s007 (0.32 MB TIF)
Figure S8 NLS-like motif in GP63 sequence. GP63 amino acid
sequence of L. mexicana with the putative NLS (nuclear localization
signals)-like motif.
Found at: doi:10.1371/journal.ppat.1001148.s008 (0.27 MB TIF)
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